Incomplete and unreadable requisitions
Orders arrive by fax, portal, phone and scanned PDF, often missing a diagnosis code, insurance detail or ordering-provider field. Each gap becomes a call back to the referrer before the sample or scan can move.
Labs & Diagnostics
Cleaner requisitions and happier referrers, with clinicians signing every result
We help labs, imaging centers and diagnostic providers reduce the admin around the test, from incomplete orders to referrer questions, while pathologists and radiologists keep authority over every result.
Short answer
How can AI help labs and diagnostic providers?
AI helps most with the paperwork around the test: reading requisitions and referral faxes, assembling imaging authorization packets, routing referrer and result queries, and supporting sales to physician groups. Diagnostic and imaging algorithms are a separate, regulated track. Pathologists and radiologists keep authority over results, and the lab validates any algorithm locally before it touches a patient report.
Who this covers
Organizations in this segment
- Independent and hospital-affiliated clinical laboratories
- Pathology services, including digital pathology groups
- Diagnostic imaging centers and radiology practices
- Specialty and reference laboratories that sell to physician groups
Challenges
The business problems that hold this segment back
Imaging authorization delays
Many imaging orders wait on prior authorization, the payer approval step that comes before the scan. Staff assemble clinical notes and payer forms by hand while the referrer and the patient wait.
Result queries that pull staff off other work
Referrers and patients call about status, delays and report copies. Client service staff must separate routine status questions from clinical questions that belong with a pathologist or radiologist.
Selling to physician groups and health systems
Contracts are won on turnaround, service and trust, across long buying cycles with several decision makers. Referrer relationships often live in one account manager's memory and a spreadsheet.
Where AI fits
Suitable AI, and how mature each application is
Established means widely deployed and well documented. Emerging means real deployments exist but results vary with your data and workflow. Early means pilots or research, not a safe default.
Requisition and referral intake
Document intelligence reads faxed and scanned requisitions, extracts patient, test and ordering-provider fields, and flags what is missing before accessioning. Low-confidence items go to a review queue and the source image stays attached. See AI automation for how we build the queue and approvals.
Imaging authorization packets
AI gathers the order, clinical notes and payer form fields into a prior authorization packet and checks request status. Staff submit and handle exceptions. It supports the request and never judges medical necessity.
Referrer and result-query routing
A text or chat assistant can answer status questions, confirm that a report is ready and pass anything clinical to a named person. We rate this emerging: bounded routing works in other settings, but the evidence we rely on is thin for labs. AI agents on voice are less mature than text.
Referrer account intelligence
Models summarize each referring practice's volume, open complaints and contract dates so account managers arrive prepared, and draft follow-ups that a person edits. It needs clean CRM data, which is why revenue operations groundwork comes first.
Clinician-support imaging triage
NHS England describes AI chest-X-ray review live across West Yorkshire association trusts, annotating findings and helping prioritize urgent cases. It supports clinicians and does not report autonomously. We help with workflow and change management, not the algorithm itself.
Digital pathology and screening algorithms
A 2025 review counted only three FDA-cleared AI/ML software-as-medical-device tools in digital pathology as of August 2025, far fewer than in radiology. England's EDITH breast-screening trial was designed for nearly 700,000 women, and the UK screening body says more evidence is needed before recommending AI image classification for routine screening.
What stays human
Responsibilities that stay with your people
Result interpretation and sign-out
Pathologists and radiologists own interpretation and sign-out. Nothing an AI tool produces goes into a patient report without their review.
Algorithm adoption decisions
The laboratory director or medical director decides whether a diagnostic algorithm is used at all, after local verification or validation and a review of its intended use.
Requisition exceptions
The accessioning lead resolves unmatched, ambiguous or urgent orders and confirms patient identity before anything is written back to the system.
Referrer questions about results
The client services lead routes inquiries, and a clinician answers anything that touches interpretation. The assistant never explains what a result means.
Improvements
Operational changes you can expect to work on
Fewer incomplete orders reaching the bench
Missing-field checks at intake catch gaps while the referrer is still reachable. The gain depends on your current rate of call-backs, which we measure first.
Authorization requests that leave complete
Packets built from the order and notes go out with fewer returns for missing information, so imaging slots are less likely to wait on paperwork.
Lighter phone load for client services
Routine status and report-ready questions are answered without a call, leaving staff time for the calls that need judgment.
One view of each referring relationship
Account managers see volume, complaints, contracts and recent contact together, so a drop in a practice's orders is noticed early rather than at renewal.
Commercial value
Where the commercial value sits
A lab or imaging provider wins volume by being easy to order from and quick to answer. Cleaner intake and faster authorization reduce lost and delayed work, and a clear referrer pipeline protects existing revenue. GTM strategy work turns that service quality into positioning for physician groups and health systems.
- Track referral volume by practice, source and test type so a decline is visible within weeks.
- Answer new physician-group and health-system inquiries with a named account contact, using a defined handoff from the website form.
- Give referring practices a portal and a regular report that answer their common questions without a call.
- Run human-written outreach to lapsed referrers, prioritized by past volume.
Rules and limits
US and UK rules that apply, and what is not ready yet
General information for planning, not legal advice. Statuses and dates are as published at the time of writing.
United States
- CLIA verification: the College of American Pathologists' 2026 submission to HHS distinguishes FDA premarket oversight from a laboratory's local CLIA verification or validation before reporting patient results. It is a professional body's position, not a new rule.
- FDA clinical decision support guidance was issued as final on 6 January 2026 and reissued on 29 January 2026. Each software function is tested against the statutory criteria, and patient- or caregiver-facing functions can still be devices.
- CMS-0057-F (final rule): payer prior authorization timeframes apply generally from 1 January 2026, with 72-hour urgent and seven-calendar-day standard decisions, and the required APIs generally from 1 January 2027. The provisions generally exclude drugs.
United Kingdom
- UK GDPR, the Data Protection Act 2018 and the Data (Use and Access) Act 2025 (Royal Assent 19 June 2025): health data needs an Article 6 basis and an Article 9 condition. The Act widens solely automated decisions for ordinary personal data, not for special-category health data.
- Selling to the NHS: a DTAC assessment covers clinical safety, data protection, technical security, interoperability, usability and accessibility, and does not confer MHRA medical device approval. DCB0129 and DCB0160 are the clinical safety standards for suppliers and deploying organizations.
- The government accepted the national commission's 44 recommendations on AI in healthcare regulation on 6 October 2026. That is policy direction, not law, and MHRA's draft guidance on adaptive AI devices is only planned for December 2026.
Not mature or not suitable yet
- Autonomous reporting or sign-out of results by AI. Clinician-support workflows exist, but the evidence does not support unsupervised reporting.
- Treating a vendor's clearance as proof of local performance, or assuming radiology adoption carries over to pathology.
- Unsupervised voice or chat assistants that disclose or explain results. Identity checks and clinical context are required, so we start with status and routing only.
- Turnaround or savings claims for admin AI in labs. The sources behind this page describe deployments and trials, not measured savings, so we set baselines before promising anything.
Services
The services that fit this segment
01AI AutomationRequisition extraction, missing-field checks and authorization packet assembly, with an exception queue that intake staff work from each day.02Data & IntegrationsConnects the lab or imaging system, billing, phone and CRM so an order, a result and an invoice read as one history, with identity matching and scoped permissions first.03Revenue OperationsReferrer source tracking and pipeline stages for accounts such as specialist practices and health systems, plus follow-up cadences for lapsed referrers.04AI GovernanceAn inventory of AI uses with a clear line between admin AI and diagnostic algorithms, and the evidence your compliance officer will be asked for.
Where to start
Where we would begin
- 01
Choose one intake lane
Pick the requisition channel that causes the most call-backs, usually fax or emailed PDFs. Measure the incomplete-order rate first, then add extraction with a review queue and a named owner.
- 02
Make referrers visible
Set up referral source tracking and a simple account view in the CRM before adding outreach tools. An early gain is seeing which practices are growing or fading.
- 03
Draw the line on diagnostic AI
List any algorithm in use or on a vendor roadmap, record its intended use and local validation status, and agree who approves it. This is where AI governance work begins.
Questions
Frequently asked questions
Can AI read and report test results?
Not autonomously. Algorithms that analyze images or specimens are often regulated devices, depending on intended use, and a pathologist or radiologist still signs the report. Our work covers the administrative pathway around the test.
Is a cleared algorithm ready to use in my lab?
Not automatically. In the US, clearance and a laboratory's local CLIA verification or validation answer different questions, and the second must happen before patient results are reported.
How strong is the evidence for AI in laboratories?
Thin for administrative AI specific to labs. The best-documented items are clinician-support imaging workflows, such as AI chest X-ray review in West Yorkshire, and document and authorization automation in other settings. Where we reason by analogy, we say so.
Can a chatbot give patients or referrers their results?
We would not start there. Results need identity verification and often clinical context. An assistant can confirm a report is ready or route the question, and a person handles anything that needs interpretation.
What about tracking on our client portal and website?
Treat it as a compliance task before a marketing one. In the US, OCR's tracking bulletin applies to pages involving protected health information, subject to the 20 June 2024 court vacatur. In the UK, advertising cookies need prior consent. We audit pixels, forms and analytics so patient details stay away from advertising vendors.
Talk through your intake and referrer workflow
Bring one requisition channel or one referrer problem. We will show where AI fits, where it does not and what to measure first. Book a discovery call to map it together.